Urgent Action Needed. The Time to Send Comments to the FDA is Now: comment period whether section 301 should be extended to include dietary supplements has been extended to November 25.
Every major news wire service was abuzz this past week over Crestor. The study released November 9 involved 18,000 patients, and supplied powerful evidence that statins save lives by driving down blood cholesterol and reducing inflammation in arteries as measured by high blood levels of C-reactive protein. In the study published in the New England Journal […]
The American Heart Association’s annual scientific session in New Orleans this month heard the presentation of a Drexel University study showing that the hospitalization rate for heart failure among older Americans increased dramatically over the past three decades.
In August, Congress enacted a law banning the phthalates (esters of phthalic acid that are mainly added to plastics to increase their flexibility) in toys and other children’s products.
The National Animal Supplement Council (NASC) was formed in 2001 to deal with the regulation of animal feed as a drug.
The FDA is currently receiving comment about Section 912 of its Amendments Act (FDAAA), which deals with the regulation of foods containing substances that have undergone clinical trials; they have now extended that comment period until November 25. The Section 912 regulations could create a major shift in the divide between foods and drugs.
According to an article in the current issue of Journal of Pediatrics, Johns Hopkins University researchers have termed the current RDA guidelines inadequate to correct the widely prevalent vitamin D deficiency in children suffering from cystic fibrosis. In their attempts to restore normal vitamin D levels, their trials used the recommended 50,000 IU of vitamin […]
Can the Public Health Effort Do More?
Integrative physicians are disproportionately the targets of state medical board action. They are often held to a different standard. Because their practice is outside the norm, the charge of “practicing outside the standard of care for the practice of medicine” is often leveled at them—even in the absence of any patient being harmed.
The topic of bisphenol A (BPA) regulation has been discussed in the September 9 and September 23 issues of Pulse of Health Freedom. Now thirty-six scientific advisers on an independent panel have concluded that the draft decision of the FDA on BPA used “unacceptable criteria for selecting data and depend(ed) heavily upon a key paper […]